CRISPR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees407
Employees407
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees407
Employees407
CRSP Key Statistics
Market cap4.39B
Market cap4.39B
Price-Earnings ratio-17.96
Price-Earnings ratio-17.96
Dividend yield—
Dividend yield—
Average volume1.59M
Average volume1.59M
High today$53.26
High today$53.26
Low today$51.01
Low today$51.01
Open price$51.40
Open price$51.40
Volume910.07K
Volume910.07K
52 Week high$91.10
52 Week high$91.10
52 Week low$43.42
52 Week low$43.42
CRSP News
TipRanks 2d
Crispr Therapeutics reports Q3 EPS ($1.01), consensus ($1.42)Reports Q3 revenue $602,000, consensus $6.81M. “We continue to make significant progress across our pipeline of in vivo and ex vivo CRISPR-based therapies,” sai...
Analyst ratings
52%
of 31 ratingsBuy
51.6%
Hold
38.7%
Sell
9.7%